Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Medical Outcomes Research Analysis LLC
FORA | US
2.04
USD-0.03
-1.45%
FORA | US
About Medical Outcomes Research Analysis LLC
Sector
Healthcare
Industry
Health Information Services
Earnings date
30/06/2024
As of date
24/03/2026
Close
2.04
Open
2.06
High
2.06
Low
2.04
Forian Inc. provides software and information solutions proprietary data driven insights and predictive analytics to optimize and measure the operational clinical and financial performance of its life science and healthcare customers. It operates through three segments: Information & Software Services and Other. The company's products include BioTrack a vertically integrated point of sale manufacturing delivery and cultivator software solution for dispensaries cultivators manufacturers and distributors; and Cannalytics a Software as a Service based analytics solution that provides customers with a presentation of business performance. Its products also comprise BioTrack seed-to-sale compliance traceability platform which is used to manage the tracking and tracing of various cannabis products from cultivation to sale; and BioTrack State Traceability & Enforcement Monitoring System to ensure transparency and accountability throughout cannabis supply chain. In addition the company offers security monitoring and web marketing services. Forian Inc. was incorporated in 2020 and is headquartered in Newtown Pennsylvania. Forian Inc.
View LessFORA | US
Risk
10.6
Sharpe
-0.11
Luna's Score
33/100
Recommendation
Sell
Luna says (FORA | US)
What's Working
Value Stock (Price to Book < 3)
What's not Working
Price Below SMA10D
High Short-term Volatility
Microcap (<300M USD)
High Market Beta (> 0.8)
High Debt to Equity (> 0.75)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
13.1%1 month
10.6%3 months
12.3%6 months
31.1%Returns
Fundamental Ratios
PE
70.33
Fwd. PE
26.39
Price to book
2.56
Debt to equity
0.86
Debt to assets
0.38
Ent. to EBITDA
18.16
Ent. to rev.
2.05
PEG
0.88
Other Fundamentals
EBITDA
-5.71M
MarketCap
63.47M
MarketCap(USD)
63.47M
Div. yield
-
Op. margin
-42.46
Erngs. growth
-
Rev. growth
-2.40
Ret. on equity
5.63
Short ratio
11.18
Short perc.
0.73
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Range10D
0.09
Range1M
0.10
Range3M
0.14
Volumes: Market Activity
Rel. volume
0.26
Price X volume
9.60K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 18.16 | - | Par |
| Ent. to Revenue | 2.05 | - | Cheaper |
| PE Ratio | 70.33 | 64.03 | Par |
| Price to Book | 2.56 | 6.17 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 12.27 | - | Lower Risk |
| Debt to Equity | 0.86 | 0.44 | Expensive |
| Debt to Assets | 0.38 | 0.35 | Par |
| Market Cap | 63.47M | - | Emerging |
